ArticleJournal of managed care & specialty pharmacy2025

Trends in first-line glucose-lowering medication use among US adults with type 2 diabetes from 2019 to 2023.

Duy Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.